PHARMACEUTICAL WATER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Pharmaceutical Water Market Size and Trends

The pharmaceutical water market size is expected to reach US$ 10.66 billion by 2030, from US$ 6.26 billion in 2023, growing at a CAGR of 7.9% during the forecast period.

Pharmaceutical Water Market Trends

• Integration with Single-Use Technologies: Pharmaceutical companies are increasing integrating single-use disposable technologies into their manufacturing operations including the use of pre-sterilized plastic bags, tubing, connectors, bioreactors, etc. Advantages such as reduced cross-contamination risks, operational flexibility, and lower capital costs are driving the shift. Pharmaceutical water system manufacturers are focusing on developing water purification solutions compatible with single-use assemblies and equipment. Integration capabilities allowing direct water dispensing into single-use components is an emerging trend.
• Rising Adoption of Remote System Monitoring: Cloud-based remote monitoring platforms are emerging as an essential feature of pharmaceutical water purification systems. IoT-enabled capabilities allow access to real-time system performance data and operational metrics through online software and mobile apps. This allows manufacturers to identify and resolve any process deviations or equipment issues proactively. Remote access provides tangible benefits such as near 24x7 monitoring, reduced site visits, and predictive maintenance capabilities. These advantages are fueling the adoption of remote monitoring.
• Automation & Connectivity with Smart Factory: The pharmaceutical manufacturing sector is gradually transitioning into a smart factory environment enabled by automation, IoT, analytics, and AI. Pharmaceutical water systems are also evolving to offer digital automation, allowing seamless integration and data exchange with production equipment, ERP, and quality management systems. Automated regulation of system operation coupled with connectivity will help minimize manual errors and enhance compliance. The shift towards automation will hence become more prevalent.
• Multi-parameter Water Quality Testing: Pharma companies are adopting a quality-by-design approach with a focus on building quality into the manufacturing process rather than by testing the final product. This demands a thorough assessment of raw material quality attributes to minimize risks. In line with this trend, there is a greater emphasis on multi-parameter testing of pharmaceutical water quality covering microbiological, chemical, physical, and elemental parameters. Regular validation of water quality will enable bespoke purification system design and robust process control.